Venus Remedies Ltd share price logo

Venus Remedies Ltd

NSE: VENUSREM

BSE: 526953

Small Cap

Pharma Sector

₹1635.00

-14.00

(-0.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Venus Remedies Stock Performance

as on July 27, 2026 at 7:45 pm IST

  • Day's Low

    Day's High

    ₹1,600.00
    ₹1,699.00
    downward going graph

    2.14%

    Downside

    3.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹424.00
    ₹2,044.30
    downward going graph

    74.07%

    Downside

    25.03%

    Upside

    downward going graph

Venus Remedies share price movements today

Previous Close
₹1,649.00
Open
₹1,649.70
Volume
27.07K
Upper Circuit
₹1,731.40
Lower Circuit
₹1,566.60
Day's Low - High
₹1,600.00 - ₹1,699.00
52 Week Low - High
₹424.00 - ₹2,044.30

Venus Remedies Historical Returns

1 Month Return
-14.56 %
3 Month Return
+ 75.93 %
1 Year Return
+ 217.73 %
3 Year Return
+ 536.31 %
5 Year Return
+ 277.56 %

Venus Remedies Fundamentals

as on July 27, 2026 at 2:15 pm IST

Market Cap

₹2,204.22 Cr

Return on Equity (ROE)

8.1

PE Ratio (TTM)

18.97

Return on capital employed (ROCE)

11.75

Industry PE ratio

51.31

Beta (LTM)

0.85

P/B Ratio

0.68

Dividend Yield

0

PEG Ratio

0.41

Quarterly Earnings Growth YOY

139.27

EPS (TTM)

33.9

Book Value

419.65

Venus Remedies Stock Valuation

as on July 27, 2026 at 2:15 pm IST

Venus Remedies in the last 5 years

  • Overview

  • Trends

Lowest (-45.34x)

September 23, 2020

Today (18.97x)

July 24, 2026

Industry (51.31x)

July 24, 2026

Highest (25.32x)

June 25, 2026

LowHigh

Today’s Price to Earnings Ratio: 18.97x

Venus Remedies Technical Analysis

Track how Venus Remedies technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish6
Bullish6
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.55
Bearish
CCI (20)
121.59
Bearish
RSI (14)
48.43
Neutral
Momentum (10)
-8
Bearish
ADI (14)
16.53
Neutral
Ultimate Oscillator (7,14,28)
33.83
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1632.72
Bearish
EMA (20)
1630.78
Bearish
VWMA (20)
1631.74
Bearish
SMA (50)
1627.56
Bullish
EMA (50)
1628.9
Bullish
SMA (200)
1625.7
Bullish
EMA (200)
1628.44
Bullish
KAMA (200)
1628.28
Bullish
DEMA (200)
1623.96
Bullish

Venus Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Venus Remedies Ltd image
Venus Remedies Ltd
NA2,204.2255.51%0.5045647
Ambalal Sarabhai Enterprises Ltd image
Ambalal Sarabhai Enterprises Ltd
NA248.222.03%0.6317202
Aarti Drugs Ltd image
Aarti Drugs Ltd
HOLD3,691.87-8.77%0.661682,387
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD15,956.88-3.06%0.002641,197
Vineet Laboratories Ltd image
Vineet Laboratories Ltd
NA73.98-12.9%0.00-2175
See all

Venus Remedies Stock’s Investor Sentiment and Interest

Investment in Venus Remedies Ltd Shares on INDmoney has dropped by -3.20% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-3.20% versus previous 30 day period

Search interest for Venus Remedies Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

Venus Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
167.72
143.42
195.16
108.61
170.1
176.52
194.97
137.18
192.75
180.26
259.4
178.86
Other Income
3.05
2.35
3.92
1.59
7.93
12.28
6.76
3.41
1.71
2.52
4.95
2.62
Total Income
170.77
145.77
199.08
110.2
178.03
188.8
201.73
140.59
194.46
182.78
264.35
181.48
Expenses
149.93
131.38
175.69
97.35
162.53
158.5
165.97
121.8
161.79
142.74
195.98
144.67
Operating Profit
17.79
12.04
19.47
11.26
7.57
18.02
29
15.38
30.96
37.52
63.42
34.19
Operating Profit Margin %
10.61%
8.39%
9.98%
10.37%
4.45%
10.21%
14.87%
11.21%
16.06%
20.81%
24.45%
19.12%
Profit Before Interest, Tax and Depreciation
20.84
14.39
23.39
12.85
15.5
30.3
35.76
18.79
32.67
40.04
68.37
36.81
Interest
0.06
0.07
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
-
Depreciation
6.44
6.54
5.91
5.98
6.41
5.41
4.71
6.18
6.17
6.56
6.75
6.77
Profit Before Tax
14.34
7.78
17.46
6.85
9.07
24.88
31.04
12.6
26.49
33.47
61.61
30.04
Tax Paid
4.4
0.93
6.95
5.63
5.56
5.28
10.04
3
6.36
7.89
14.11
7.07
Profit After Tax
9.94
6.85
10.51
1.22
3.51
19.6
21
9.6
20.13
25.58
47.5
22.97
Total Net profit including share of profit / Loss from associate company
9.94
6.85
10.51
1.22
3.51
19.6
21
9.6
20.13
25.58
47.5
22.97
EPS
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
35.53
17.18
Actual EPS
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
35.53
17.18
Adjusted EPS
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
35.53
17.18
Diluted EPS
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
25.53
17.18

Venus Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
372.41
321.89
341.46
548.12
600.18
555.51
601.45
652.89
769.6
Other Income
2.26
6.09
5.31
43.07
8.31
10.32
11.58
25.86
12.58
Total Income
374.67
327.99
346.77
591.2
608.49
565.83
613.03
678.75
782.18
Expenses
332.94
298.33
309.49
494.35
538.07
495.49
541.85
584.35
622.32
Operating Profit
39.47
23.56
31.97
53.77
62.11
60.02
59.6
68.54
147.28
Operating Profit Margin %
10.6%
7.32%
9.36%
9.81%
10.35%
10.8%
9.91%
10.5%
19.14%
Profit Before Interest, Tax and Depreciation
41.73
29.66
37.29
96.85
70.42
70.34
71.18
94.4
159.86
Interest
35.43
25.41
13.31
13.02
0.48
0.12
0.09
0.07
0.04
Depreciation
33.83
33.98
32.01
35.28
33.53
32.3
26.45
22.51
25.66
Profit Before Tax
-27.53
-29.73
-8.03
48.55
36.41
37.92
44.64
71.82
134.16
Tax Paid
3.16
-1.15
1.96
-13.21
-4.32
11.36
16.16
26.5
31.37
Profit After Tax
-30.69
-28.58
-10
61.77
40.73
26.56
28.48
45.32
102.79
Total Net profit including share of profit / Loss from associate company
-30.69
-28.58
-10
61.77
40.73
26.56
28.48
45.32
102.79
EPS
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
76.89
Actual EPS
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
76.89
Adjusted EPS
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
76.89
Diluted EPS
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
76.89

Venus Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
46.88
58.93
31.19
45.33
77.6
131.84
41.1
36.63
37.29
86.44
Cash Flow from Investing Activities
3.39
-22.82
20.25
-1.41
-4.69
57.34
-17.24
-58.11
-8.46
-76.86
Cash Flow from Financing Activities
-46.35
-44.12
-39.23
-35.17
-73
-162.24
-9.48
-0.57
-1.08
-1.02
Net Cash Flow
3.46
-3.51
0.42
-1.17
-0.09
26.94
14.38
-22.04
27.74
8.57

Venus Remedies Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
DII
0.15%
0.15%
0.15%
0.15%
0.15%
0%
0%
0.11%
0.75%
1.03%
1.2%
0.89%
FII
1.03%
1.59%
1.48%
1.06%
1.18%
1.11%
1.34%
2.24%
1.86%
2.26%
2.8%
2.92%
Public
57.07%
56.5%
56.61%
57.03%
56.91%
57.13%
56.9%
55.89%
55.63%
54.96%
54.24%
54.43%
Total Outstanding Shares
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
Total Shareholders
19,267
19,560
19,913
19,614
19,557
19,771
19,982
19,307
17,725
18,606
18,403
21,905

Venus Remedies Corporate Actions

View detailed summary of the earnings and dividend history of Venus Remedies.

  • Venus Remedies Ltd Earnings Results

    Venus Remedies Ltd’s net profit jumped 139.27% since last year same period to ₹22.97Cr in the Q1 2026-2027. On a quarterly growth basis, Venus Remedies Ltd has generated -51.64% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Venus Remedies Ltd Dividends May,2026

    In the quarter ending March 2026, Venus Remedies Ltd has declared dividend of ₹10.00 per share on 26 May 2026 - translating a dividend yield of 0.61%.

    Read More about Dividends

Insights on Venus Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.80% to 2.92% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 54.24% to 54.43% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.76% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, VENUSREM stock has moved down by -14.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 47.5 Cr → 22.97 Cr (in ₹), with an average decrease of 51.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 264.35 Cr → 181.48 Cr (in ₹), with an average decrease of 31.4% per quarter

About Venus Remedies Ltd

Established in 1989, Venus Remedies Limited is a family managed company based out of Panchkula district at Haryana, India. The company specializes in Intravenous/Intramuscular injectible forms and Eye/Ear/Nose drops and has been GMP certified by the WHOGeneva. In 2001, Venus Remedies had tied up with a top Australian company to set-up a Cephalosporin project at a cost of Rs 4.5 crores. The company is also manufacturing injections for leading firms like Panacea Biotech and Morepan Laboratories among others. Over the years, Venus Remedies has been able to successfully introduce 13 new products in their Animal Health division, which include names like Megox3000, Paroxin3000, Pisa3000, MicalRonid and Dexolyte, to name a few.

Revenue: ₹178.86Cr as on June 2026 (Q1 FY27)
Net Profit: ₹22.97Cr as on June 2026 (Q1 FY27)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
OrganisationVenus Remedies Ltd
HeadquartersPanchkula
IndustryPharmaceuticals
CEOPawan Chaudhary
E-voting on sharesClick here to vote

FAQs

What is Venus Remedies share price today?

Venus Remedies share price today stands at ₹1635 as on . Venus Remedies share today touched a day high of ₹1699 and a low of ₹1600.

What is the 52 week high and 52 week low range for Venus Remedies share?

Venus Remedies touched a 52 week high of ₹2044.3 and a 52 week low of ₹424. Venus Remedies share price today i.e. is trending at ₹1635, which is -20.02% down from its 52 week high and 285.61% up from its 52 week low.

What is Venus Remedies's market capitalisation today?

Venus Remedies market capitalisation is ₹2,204.22 Cr as on .

How to buy Venus Remedies shares?

To buy Venus Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VENUSREM or Venus Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Venus Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Venus Remedies trading volume today?

Venus Remedies trading volume is 27.07K as on . This means that 27.07K shares of Venus Remedies were bought and sold on the stock market during today's trading session.